3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Blast Crisis
3
Osteosarcoma
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Down Syndrome
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Urothelial Carcinoma of the Bladder
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
atezolizumab
2
cabozantinib
1
Specimen Handling
1
Immunoglobulin G
1
Disulfides
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
Methotrexate
×
30 days
×
Clear all
No trials found.